SEC Filings TLDR

Paysign, Inc. has entered into a Stipulation and Agreement of Settlement to resolve multiple stockholder derivative actions pending in the United States District Court for the District of Nevada. The derivative actions alleged violations of Sections 10(b) and 14(a) of the Exchange Act, breaches of fiduciary duty, unjus...

Pasithea Therapeutics Corp. announced the activation of two clinical trial sites in South Korea for its Phase 1/1b open-label study of PAS-004 in adult patients with neurofibromatosis type 1 (NF1). The sites, Asan Medical Centre and Severance Hospital Yonsei University Health System, are now actively recruiting partici...

On September 12, 2025, Paramount Skydance Corporation announced the appointment of Dennis Cinelli to its Board of Directors. Mr. Cinelli was also appointed to the Audit Committee of the Board, effective immediately. Concurrently, Sherry Lansing stepped down from the Audit Committee. Mr. Cinelli is eligible to participa...

On September 14, 2025, Peloton Interactive, Inc. announced a comprehensive redesign of its executive compensation program. The changes, approved by the Compensation Committee, aim to strengthen the company's pay-for-performance philosophy and align with market practices. Key changes include transitioning leadership tea...

On September 11, 2025, Ovid Therapeutics Inc. received a formal notification from The Nasdaq Stock Market LLC confirming that the company has regained compliance with Nasdaq Listing Rule 5550(a)(2). This rule requires listed companies to maintain a minimum bid price of at least $1.00 per share. The notification also st...

On September 10, 2025, Tod Wagenhals, the Executive Vice President and Secretary of Outdoor Holding Company, resigned from his position as Secretary effective immediately and as Executive Vice President effective December 31, 2025. In connection with his resignation, the Board of Directors appointed Jordan Christensen,...

Oscar Health, Inc. has announced the termination of its revolving credit facility as part of its senior secured credit agreement, contingent upon the closing of its private offering of $355 million in 2.25% Convertible Senior Subordinated Notes due 2030. The notes are being offered to qualified institutional buyers und...

On September 11, 2025, Ocugen, Inc. entered into an Exclusive License Agreement with Kwangdong Pharmaceutical Co., Ltd. Under this agreement, Kwangdong was granted an exclusive, non-sublicensable, royalty-bearing license to import, export, distribute, use, and sell OCU400, Ocugen's novel modifier gene therapy for retin...

Ocean Power Technologies, Inc. (OPT) reported its financial results for the first quarter of fiscal year 2026, ending July 31, 2025. The company announced a significant increase in backlog, which surged 184% to $15.0 million compared to the same period last year. However, revenues decreased by 9% to $1.2 million, and t...

On September 16, 2025, Oxbridge Re Holdings Limited filed a prospectus supplement to its Registration Statement on Form S-3, allowing the company to sell $2,021,889 of its ordinary shares. This filing is part of an equity distribution agreement with Maxim Group LLC. As of the filing date, the company had already sold $...

Optical Cable Corporation (OCC) reported its third quarter fiscal year 2025 financial results, showing significant growth in net sales and gross profit. Consolidated net sales increased by 22.8% to $19.9 million compared to the same period last year, driven by growth in both enterprise and specialty markets. Gross prof...

On September 15, 2025, Office Properties Income Trust announced the appointment of John Castellano, a Partner and Managing Director of AlixPartners, LLP, as Chief Restructuring Officer. AlixPartners had previously been engaged to support the company's restructuring efforts. This appointment is part of the company's ong...

Nuvve Holding Corp. (the 'Company') issued additional senior convertible promissory notes and warrants to an investor on September 10, 2025, as part of the exercise of an Additional Investment Right under a previously disclosed securities purchase agreement. The additional note has a principal amount of $111,111.11, ca...

On September 15, 2025, Nukkleus Inc. (the "Company") entered into an Amended and Restated Securities Purchase Agreement and Call Option (the "Star Agreement") with Star 26 Capital Inc. ("Star"), the shareholders of Star, and Menachem Shalom, the representative of such shareholders. The Star Agreement amends and restate...

Neuphoria Therapeutics Inc. (the 'Company') received a deficiency notification letter from Nasdaq on July 18, 2025, for failing to hold an annual general meeting of stockholders within twelve months of the end of its fiscal year ended June 30, 2024. The Company submitted a plan to regain compliance, which Nasdaq accept...

Nauticus Robotics, Inc. filed a Form 8-K on September 16, 2025, which included an opinion from Norton Rose Fulbright US LLP regarding the company's at-the-market (ATM) offering. The ATM Agreement, dated May 20, 2024, allows Nauticus Robotics to issue and sell up to $2,200,000 of its common stock. The opinion confirms t...

News Corporation filed a Form 8-K on September 15, 2025, providing an update on its stock repurchase programs. The company is authorized to acquire up to $1 billion in aggregate of its outstanding Class A and Class B common stock under the 2021 Repurchase Program and an additional $1 billion under the 2025 Repurchase P...

On September 14, 2025, Microbot Medical Inc. entered into an inducement agreement with certain holders of existing preferred investment options (PIOs) to purchase shares of the company's common stock. The agreement involves the issuance of new series J preferred investment options (New PIOs) to purchase up to 13,989,11...

Medtronic plc announced the pricing of its senior notes offering on September 15, 2025. The company plans to issue €750 million of 2.950% Senior Notes due 2030 and €750 million of 4.200% Senior Notes due 2045. The net proceeds from the offering are expected to be used to repay Medtronic Global Holdings S.C.A.’s 0.000% ...

On September 12, 2025, Christopher Briggs tendered his resignation from his position as the Chief Product Officer of Mitek Systems, Inc., effective September 19, 2025. The resignation was not due to any disagreement with the company regarding its operations, policies, or practices. This filing, Form 8-K, was submitted ...

MercadoLibre, Inc. has entered into Amendment No. 1 to its Amended and Restated Revolving Credit Agreement, dated September 12, 2025. The amendment allows the company to request additional commitments from existing or new lenders, increasing the total credit commitments to up to $800,000,000. The amendment also restate...

Marchex, Inc. announced significant changes to its executive team on September 16, 2025. Edwin Miller, the CEO, stepped down and will serve as a senior advisor to the Chairman. Troy Hartless, the Chief Revenue Officer, was appointed President. Francis Feeney, the Chief Corporate and Legal Affairs Officer, was appointed...

On September 16, 2025, Magnite, Inc. filed a lawsuit in the U.S. District Court for the Eastern District of Virginia against Google LLC seeking financial damages and other remedies. This action follows a U.S. District Court ruling that Google had engaged in unlawful anticompetitive practices in certain ad tech markets....

On September 15, 2025, Charles Newton, the Chief Financial Officer (CFO) and principal financial and accounting officer of Lyell Immunopharma, Inc., notified the company of his decision to resign, effective October 31, 2025. The resignation was not due to any disagreements with the company. Lyell Immunopharma plans to ...

Lightwave Logic, Inc. entered into a new employment agreement with Yves LeMaitre, its Chief Executive Officer, on September 12, 2025. The agreement includes an annual base salary of $500,000, eligibility for an annual cash bonus of up to $300,000, and equity awards totaling 826,617 restricted stock units (RSUs) under t...